MCRB
Seres Therapeutics Inc
3.80$
-5.7%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
Seres Therapeutics Inc (MCRB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -22 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -59 | -47 | -35 | -40 | -35 | -39 | 27 | -13 | 2.2 | -15 | -16 | -22 | -51 | |
| 1.7 | 1.6 | 1.6 | 1.4 | 1.4 | 1.1 | 1.1 | 1.1 | 1.0 | 1.0 | 0.8 | 0.7 | 3.4 | |
| 8.7 | 5.1 | 6.5 | 5.5 | 5.2 | 3.8 | 2.8 | 2.3 | 2.5 | 3.2 | 1.8 | 1.7 | 9.2 | |
| -23 | -15 | -9.2 | -17 | 26 | -30 | -12 | 1.1 | -12 | -5.5 | -1.2 | -37 | -56 | |
| 1.8 | 0.9 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -1.8 | -0.9 | -0.1 | 1.3 | 141 | -0.1 | 0.0 | -0.2 | 0.0 | 0.2 | – | 0.0 | – | |
| – | – | – | – | -128 | 0.0 | – | – | – | 0.0 | – | – | – | |
| 1.4 | 6.4 | 19 | 0.0 | -111 | 1.7 | 1.2 | 0.0 | 0.1 | 13 | 0.4 | 1.7 | 15 | |
| -60 | -42 | -17 | -39 | -4.4 | -37 | 28 | -13 | 2.3 | -1.9 | -16 | -21 | -36 | |
| -61 | -48 | -35 | -40 | -35 | -39 | 27 | -13 | 2.2 | -15 | -16 | -22 | -51 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.